Century Therapeutics
Dr. Ellen Rothenberg studies the molecular mechanisms that are responsible for developmental lineage choice as hematopoietic stem cells differentiate into T lymphocytes. Her work is focused on identifying the transcription factors and signaling events that induce T-lineage gene expression in an uncommitted precursor and determining how they work to force the cell to relinquish other developmental options.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Century Therapeutics
1 followers
Century Therapeutics is harnessing the power of stem cells to develop curative cell therapy products for cancer.